Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
8,265 USD | -1,72% | -7,83% | +103,31% |
01/03 | SANA BIOTECHNOLOGY, INC. : JMP Securities ontvangt een koopadvies | ZM |
01/03 | Aandelen Sana Biotechnology stijgen na kleiner niet-GAAP nettoverlies in Q4 | MT |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 1,85 mld. 1,74 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -241 mln. -226 mln. | Nettowinst (verlies) 2025 * | -308 mln. -289 mln. | EV/omzet 2024 * | - |
Nettoschuld 2024 * | 5,58 mln. 5,23 mln. | Nettoliquiditeiten 2025 * | 285 mln. 267 mln. | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-7,41
x | K/w-verhouding 2025 * |
-6,73
x | Werknemers | 328 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 90,84% |
Recentste transcriptie over Sana Biotechnology, Inc.
1 dag | -1,72% | ||
1 week | -7,83% | ||
Lopende maand | -17,05% | ||
1 maand | -6,90% | ||
3 maanden | +35,54% | ||
6 maanden | +166,72% | ||
Lopend jaar | +103,31% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Steven Harr
FOU | Founder | 53 | 13-07-18 |
Nathan Hardy
DFI | Director of Finance/CFO | 48 | 01-09-18 |
Gary Meininger
CTO | Chief Tech/Sci/R&D Officer | - | 10-04-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 69 | 01-05-20 | |
Patrick Yang
BRD | Director/Board Member | 75 | 01-10-18 |
Robert Nelsen
FOU | Founder | 60 | 13-07-18 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.07% | 2 M€ | -.--% | ||
0.05% | 0 M€ | 0,00% | - | |
0.03% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
17-04-24 | 8,28 | -1,55% | 528 283 |
16-04-24 | 8,41 | -1,64% | 1 364 022 |
15-04-24 | 8,55 | -4,58% | 1 675 518 |
12-04-24 | 8,96 | -4,27% | 1 469 457 |
11-04-24 | 9,36 | +4,00% | 868 045 |
uitgestelde koers Nasdaq, 17 april 2024 om 20:26 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+103,31% | 1,85 mld. | |
-1,36% | 41,71 mld. | |
+47,70% | 41,56 mld. | |
+3,83% | 39,74 mld. | |
-15,14% | 25,61 mld. | |
+3,29% | 24,26 mld. | |
-23,09% | 18,55 mld. | |
-2,20% | 11,93 mld. | |
+25,43% | 11,93 mld. | |
+7,43% | 10,91 mld. |